PI
Specialization
Vascular Medicine and lipoprotein metabolism
Focus of research
- Pathogenesis of atherosclerosis
- Treatment of increased cardiovascular risk
Amsterdam Cardiovascular Sciences
-
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials
Burger, P. M., Dorresteijn, J. A. N., Koudstaal, S., Holtrop, J., Kastelein, J. J. P., Jukema, J. W., Ridker, P. M., Mosterd, A. & Visseren, F. L. J., 1 Sept 2024, In: Atherosclerosis. 396, 118540.Research output: Contribution to journal › Article › Academic › peer-review
-
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI
Povsic, T. J., Korjian, S., Bahit, M. C., Chi, G., Duffy, D., Alexander, J. H., Vinereanu, D., Tricoci, P., Mears, S. J., Deckelbaum, L. I., Bonaca, M., Ridker, P. M., Goodman, S. G., Cornel, J. H., Lewis, B. S., Parkhomenko, A., Lopes, R. D., Aylward, P., Lincoff, A. M., Heise, M., & 18 others, 4 Jun 2024, In: Journal of the American College of Cardiology. 83, 22, p. 2163-2174 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Correction to: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial (Nature Medicine, (2023), 29, 7, (1782-1792), 10.1038/s41591-023-02427-z)
Bhatt, D. L., Bays, H. E., Miller, M., Cain, J. E., Wasilewska, K., Andrawis, N. S., Parli, T., Feng, S., Sterling, L., Tseng, L., Hartsfield, C. L., Agollah, G. D., Mansbach, H. & ENTRIGUE Principal Investigators, Jun 2024, In: Nature medicine. 30, 6, p. 1788-1789 2 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications